Berardelli Isabella, Serafini Gianluca, Cortese Natalia, Fiaschè Federica, O'Connor Rory C, Pompili Maurizio
Department of Neurosciences, Mental Health and Sensory Organs, Faculty of Medicine and Psychology, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, 00100 Rome, Italy.
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, IRCCS San Martino, Largo Rosanna Benzi 10, 16100 Genoa, Italy.
Brain Sci. 2020 Sep 21;10(9):653. doi: 10.3390/brainsci10090653.
Stress and Hypothalamic-Pituitary-Adrenal (HPA) axis dysregulation play a major role in various pathophysiological processes associated with both mood disorders and suicidal behavior. We conducted a systematic review with the primary aim of clarifying the nature and extent of HPA axis activity and suicidal behavior. The second aim of this review was to investigate whether potential biomarkers related to HPA axis abnormalities act as individual susceptibility factors for suicide. The PRISMA statement for reporting systematic reviews was used. Only articles published in English peer-reviewed journals were considered for possible inclusion; we excluded case reports, meta-analyses, and systematic reviews, and studies that did not clearly report statistical analysis, diagnostic criteria, or the number of patients included. Overall, 36 articles on HPA axis and suicide risk met inclusion criteria and were reviewed. Studies that investigated tests detecting biomarkers and the role of early life stressors in suicide risk were also included. We found that HPA axis activity is involved in suicide risk, regardless of the presence or absence of psychiatric conditions. The HPA axis abnormalities, mainly characterized by hyperactivity of the HPA axis, may exert an important modulatory influence on suicide risk. Impaired stress response mechanisms contribute to suicide risk. Targeting HPA axis dysregulation might represent a fruitful strategy for identifying new treatment targets and improving suicide risk prediction.
压力与下丘脑 - 垂体 - 肾上腺(HPA)轴功能失调在与情绪障碍和自杀行为相关的各种病理生理过程中起主要作用。我们进行了一项系统综述,主要目的是阐明HPA轴活动与自杀行为的性质和程度。本综述的第二个目的是研究与HPA轴异常相关的潜在生物标志物是否作为自杀的个体易感性因素。采用了报告系统综述的PRISMA声明。仅考虑发表在英文同行评审期刊上的文章是否可能被纳入;我们排除了病例报告、荟萃分析和系统综述,以及未明确报告统计分析、诊断标准或纳入患者数量的研究。总体而言,36篇关于HPA轴与自杀风险的文章符合纳入标准并进行了综述。研究检测生物标志物的测试以及早期生活应激源在自杀风险中的作用的研究也被纳入。我们发现,无论是否存在精神疾病,HPA轴活动都与自杀风险有关。HPA轴异常主要表现为HPA轴功能亢进,可能对自杀风险产生重要的调节影响。应激反应机制受损会导致自杀风险。针对HPA轴功能失调可能是识别新治疗靶点和改善自杀风险预测的有效策略。